Remimazolam Besylate

CHEMBL4594301 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

597.5 g/mol

LogP

—

Phase

4

Remimazolam besylate is the besylate salt form of remimazolam, an ultra-short-acting esterase-metabolized benzodiazepine used for procedural sedation and general anesthesia induction with rapid and predictable offset. See remimazolam for complete pharmacological details.

Masse moléculaire

597,5000 g/mol

TPSA

132,00 Å²

Aires thérapeutiques

Respiratory Disease Pain Management Generalized Anxiety Disorder Chronic Kidney Disease Obesity

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.O=S(=O)(O)c1ccccc1

InChI

InChI=1S/C21H19BrN4O2.C6H6O3S/c1-13-12-24-21-17(7-9-19(27)28-2)25-20(16-5-3-4-10-23-16)15-11-14(22)6-8-18(15)26(13)21;7-10(8,9)6-4-2-1-3-5-6/h3-6,8,10-12,17H,7,9H2,1-2H3;1-5H,(H,7,8,9)/t17-;/m0./s1

Molecular Formula

C27H25BrN4O5S

HBD / HBA

1 / 8

Liaisons Rotatives

6

Atomes Lourds

38

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Remimazolam besylate is the besylate salt form of remimazolam, an ultra-short-acting esterase-metabolized benzodiazepine used for procedural sedation and general anesthesia induction with rapid and predictable offset. See remimazolam for complete pharmacological details.

Yes, Remimazolam Besylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4594301. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 23658607. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Remimazolam Besylate sur PillFYI

Structure

Données Clés

Formule: C27H25BrN4O5S
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.